Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
- 2020 SS
- 2019 WS
- 2019 SS
- 2018 WS
- 2018 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myelomaIn: Blood Cancer Journal Jg. 11 (2021) Nr. 1, S. 1
ISSN: 2044-5385Online Volltext: dx.doi.org/ (Open Access) -
Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trialsIn: Leukemia Jg. 35 (2021) Nr. 1, S. 169 - 176
ISSN: 1476-5551; 0887-6924Online Volltext: dx.doi.org/ -
Anti-leukemic effect of CDK9 inhibition in T-cell prolymphocytic leukemiaIn: Therapeutic Advances in Hematology Jg. 11 (2020) S. 1 - 15
ISSN: 2040-6207; 2040-6215Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageIn: Leukemia (2020)
ISSN: 1476-5551; 0887-6924Online Volltext: dx.doi.org/ -
CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivoIn: PLoS ONE Jg. 15 (2020) Nr. 2, S. e0228674
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
Identifying genetic lesions in ocular adnexal extranodal marginal zone lymphomas of the malt subtype by whole genome, whole exome and targeted sequencingIn: Cancers Jg. 12 (2020) Nr. 4, S. 986
ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Mutations in PIGA cause a CD52-/GPI-anchor-deficient phenotype complicating alemtuzumab treatment in T-cell prolymphocytic leukemiaIn: European Journal of Haematology Jg. 105 (2020) Nr. 6, S. 786 - 796
ISSN: 1600-0609; 0902-4441; 0036-553XOnline Volltext: dx.doi.org/ (Open Access) -
Noncanonical effector functions of the T-memory–like T-PLL cell are shaped by cooperative TCL1A and TCR signalingIn: Blood Jg. 136 (2020) Nr. 24, S. 2786 - 2802
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemiaIn: Genes, chromosomes & cancer Jg. 59 (2020) Nr. 4, S. 261 - 267
ISSN: 1098-2264; 1045-2257Online Volltext: dx.doi.org/ (Open Access) -
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trialIn: Leukemia Jg. 34 (2020) Nr. 7, S. 1853 - 1865
ISSN: 1476-5551; 0887-6924Online Volltext: dx.doi.org/ -
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone : results of the phase II PERSPECTIVE Multiple Myeloma trialIn: Blood Cancer Journal Jg. 9 (2019) Nr. 4, S. 45
ISSN: 2044-5385Online Volltext: dx.doi.org/ (Open Access) -
Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patientsIn: Blood Cancer Journal Jg. 9 (2019) Nr. 2, S. 13
ISSN: 2044-5385Online Volltext: dx.doi.org/ (Open Access) -
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaIn: Leukemia Jg. 33 (2019) Nr. 2, S. 390 - 402
ISSN: 1476-5551; 0887-6924Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma : Results from the phase III GMMG-HD4 and -MM5 trialsIn: Clinical Lymphoma Myeloma and Leukemia Jg. 19 (2019) Nr. 10, S. e43
ISSN: 2152-2650Online Volltext: dx.doi.org/ -
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myelomaIn: Blood Cancer Journal Jg. 9 (2019) Nr. 9, S. 71
ISSN: 2044-5385Online Volltext: dx.doi.org/ (Open Access) -
Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG miceIn: Scientific Reports Jg. 9 (2019) S. 12914
ISSN: 2045-2322Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLLIn: Cancers Jg. 11 (2019) Nr. 12, S. 1833
ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access) -
New lessons learned in T-PLL : results from a prospective phase-II trial with fludarabine–mitoxantrone–cyclophosphamide–alemtuzumab induction followed by alemtuzumab maintenanceIn: Leukemia and Lymphoma Jg. 60 (2019) Nr. 3, S. 649 - 657
ISSN: 1029-2403; 1042-8194Online Volltext: dx.doi.org/ -
Normalization of serum free light chains during therapy in the MM5 trial predicts prolonged progression free survival and overall survivalIn: Clinical Lymphoma Myeloma & Leukemia Jg. 19 (2019) Nr. 10, S. e208
ISSN: 2152-2650Online Volltext: dx.doi.org/ -
Pomalidomide + Bortezomib + Dexamethasone After One Prior Line of Therapy in Bortezomib-Pretreated Multiple Myeloma : Subanalysis of OPTIMISMMIn: Clinical Lymphoma Myeloma and Leukemia Jg. 19 (2019) Nr. 10, S. e32 - e33
ISSN: 2152-2650Online Volltext: dx.doi.org/ -
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6 : A randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myelomaIn: BMC Cancer Jg. 19 (2019) Nr. 1, S. 504
ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access) -
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP : results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trialIn: Annals of Hematology Jg. 98 (2019) Nr. 4, S. 897 - 907
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ -
Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort StudyIn: Annals of Hematology Jg. 98 (2019) Nr. 12, S. 2761 - 2767
ISSN: 0006-5242; 0939-5555Online Volltext: dx.doi.org/ -
Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy) : A study protocol for a single-arm, non-randomized, open, national, multi-center phase II trialIn: Trials Jg. 20 (2019) Nr. 1, S. 544
ISSN: 1745-6215Online Volltext: dx.doi.org/ (Open Access) -
Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus–infected individualsIn: Blood Jg. 131 (2018) Nr. 5, S. 546 - 557
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ (Open Access) -
Drug-perturbation-based stratification of blood cancerIn: Journal of Clinical Investigation Jg. 128 (2018) Nr. 1, S. 427 - 445
ISSN: 1558-8238; 0021-9738Online Volltext: dx.doi.org/ (Open Access) -
Four versus Two Years of Rituximab Maintenance (R-Maintenance) Following Bendamustine Plus Rituximab (B-R) : Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN Study)In: Clinical Lymphoma Myeloma and Leukemia Jg. 18 (2018) Nr. Suppl. 1, S. S101 - S103
ISSN: 2152-2650Online Volltext: dx.doi.org/ -
Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study : Influence of chemotherapy on efficacy and safetyIn: Journal of Clinical Oncology Jg. 36 (2018) Nr. 23, S. 2395 - 2404
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ (Open Access) -
Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysisIn: Annals of Hematology Jg. 97 (2018) Nr. 8, S. 1463 - 1469
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ -
Magnetic resonance imaging before and after upfront autologous transplantation identifies patients with adverse outcome but response to treatment within the prospective GMMG MM5 phase III trialIn: Haematologica Jg. 103 (2018) Nr. Suppl. 1, S. 11 - 12
ISSN: 1592-8721; 0390-6078 -
Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemiaIn: Nature Communications Jg. 9 (2018) S. 3839
ISSN: 2041-1723Online Volltext: dx.doi.org/ (Open Access) -
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL) : A Multicenter, Randomized Phase III TrialIn: Journal of Clinical Oncology Jg. 36 (2018) Nr. 20, S. 2024 - 2034
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemiaIn: OncoTarget Jg. 9 (2018) Nr. 41, S. 26353 - 26369
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
Rituximab with Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma : Results of the MIR StudyIn: HemaSphere: Open access journal of the European Hematology Association Jg. 2 (2018) Nr. 6, S. e160
ISSN: 2572-9241Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaIn: Blood Cancer Journal Jg. 8 (2018) Nr. 1, S. 11
ISSN: 2044-5385Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myelomaIn: OncoImmunology Jg. 7 (2018) Nr. 10, S. e1486356
ISSN: 2162-402X; 2162-4011Online Volltext: dx.doi.org/ -
Associations of ofatumumab exposure and treatment outcomes in patients with untreated CLL receiving chemoimmunotherapyIn: Leukemia and Lymphoma Jg. 58 (2017) Nr. 2, S. 348 - 356
ISSN: 1029-2403; 1042-8194Online Volltext: dx.doi.org/ -
Circulating tumor cells as a biomarker for response to therapy in multiple myeloma patients treated within the GMMG-MM5 trialIn: Bone Marrow Transplantation Jg. 52 (2017) Nr. 8, S. 1194 - 1198
ISSN: 0268-3369; 1476-5365Online Volltext: dx.doi.org/ (Open Access) -
Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trialIn: OncoTarget Jg. 8 (2017) Nr. 49, S. 84847 - 84862
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemiaIn: Cancer Jg. 123 (2017) Nr. 5, S. 814 - 823
ISSN: 0008-543X; 1097-0142Online Volltext: dx.doi.org/ -
Immunochemotherapy with obinutuzumab or rituximab in previously untreated follicular lymphoma in the randomized phase III gallium study : analysis by chemotherapy regimenIn: Haematologica Jg. 102 (2017) Nr. Suppl. 2, S. 314
ISSN: 0390-6078; 1592-8721 -
Is long-term particulate matter and nitrogen dioxide air pollution associated with incident monoclonal gammopathy of undetermined significance (MGUS)? : An analysis of the Heinz Nixdorf Recall studyIn: Environment International Jg. 108 (2017) S. 237 - 245
ISSN: 1873-6750; 0160-4120Online Volltext: dx.doi.org/ -
Longitudinal analysis of light-chain monoclonal gammopathy of undetermined significance-10-year follow up of the population-based Heinz Nixdorf Recall studyIn: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 81 Abstract P292
ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240Online Volltext: dx.doi.org/ -
NOTCH-signaling in the tumor microenvironment is required for canonical WNT signaling in CLL cellsIn: Leukemia and Lymphoma Jg. 58 (2017) Nr. Suppl. 1, XVII International Workshop on Chronic Lymphocytic Leukemia 2017 May 12--15, 2017, New York, S. 125 - 126
ISSN: 1042-8194; 1029-2403Online Volltext: dx.doi.org/ -
Successful treatment of cerebral aspergillosis: Case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)In: BMC Infectious Diseases Jg. 17 (2017) S. 797
ISSN: 1471-2334Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Tumor-derived exosomes modulate PD-L1 expression in monocytesIn: Science Immunology Jg. 2 (2017) Nr. 13,
ISSN: 2470-9468Online Volltext: dx.doi.org/ -
Activity of the CD40 antagonistic antibody lucatumumab - insights from CLL-niche mimicking xenografts and fludarabine combinationsIn: Leukemia and Lymphoma Jg. 57 (2016) Nr. 9, S. 2235 - 2238
ISSN: 1042-8194; 1029-2403Online Volltext: dx.doi.org/ -
Bendamustine triggered paraneoplastic pemphigus in a patient with chronic lymphocytic leukemiaIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 257 - 258
ISSN: 2296-5270; 2296-5262 -
Chronic Lymphocytic Leukemia-Derived Extracellular Vesicles Mediate NF kappa B Signaling and Pro-Inflammatory Cytokine Release in MonocytesIn: Journal of Immunology Jg. 196 1 (2016) -
ISSN: 0022-1767 -
Chronic lymphocytic leukemia-derived extracellular vesicles mediate NFkB signaling and pro-inflammatory cytokine release in monocytesIn: Cancer Research Jg. 76 15 (2016) -
ISSN: 0008-5472; 1538-7445Online Volltext: dx.doi.org/ -
Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cellsIn: Cell Death Discovery Jg. 2 (2016) S. 16010
ISSN: 2058-7716 -
Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia : Results of the CLL9 trial of the German CLL study groupIn: Leukemia and Lymphoma Jg. 57 (2016) Nr. 4, S. 789 - 796
ISSN: 1042-8194; 1029-2403Online Volltext: dx.doi.org/ -
Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemiaIn: British Journal of Haematology Jg. 173 (2016) Nr. 2, S. 265 - 273
ISSN: 0007-1048; 1365-2141Online Volltext: dx.doi.org/ -
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia : data from the prospective, multicenter phase-II CLL-009 trialIn: Blood Cancer Journal Jg. 6 (2016) S. e404
ISSN: 2044-5385Online Volltext: dx.doi.org/ (Open Access) -
Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trialIn: Haematologica Jg. 101 (2016) Nr. 12, S. e485 - e487
ISSN: 0390-6078; 1592-8721Online Volltext: dx.doi.org/ (Open Access) -
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemiaIn: International Journal of Cancer Jg. 138 (2016) Nr. 1, S. 121 - 124
ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access) -
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomasIn: OncoTarget Jg. 7 (2016) Nr. 38, S. 62627 - 62639
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trialIn: Leukemia and Lymphoma Jg. 57 (2016) Nr. 6, S. 1291 - 1299
ISSN: 1029-2403; 1042-8194Online Volltext: dx.doi.org/ -
Subcutaneous rituximab in patients with DLBCL and follicular NHL - First interim results from the non-interventional study MabSCaleIn: Oncology Research and treatment Jg. 39 3 (2016) S. 156 - 156
ISSN: 2296-5270 -
Elevated levels of soluble HLA-E and the presence of HLA-E*01:03 predict disease of progression in CLLIn: Tissue Antigens Jg. 86 (2015) Nr. 2, S. 85 - 86
ISSN: 0001-2815; 1399-0039 -
Functional abnormalities and changes in gene expression in fibroblasts and macrophages from the bone marrow of patients with acute myeloid leukemiaIn: International Journal of Hematology Jg. 102 (2015) Nr. 3, S. 278 - 288
ISSN: 1865-3774; 0925-5710Online Volltext: dx.doi.org/ -
Immunoglobulin M Heavy/Light Chain Pair Measurement Independently Predicts Clinical Outcome and Refines Prognostic Information Provided By Interim PET in Patients with Aggressive LymphomasIn: Blood Jg. 126 (2015) Nr. 23,
ISSN: 0006-4971; 1528-0020 -
Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages (vol 3, 1058, 2014)In: Stem Cell Reports Jg. 5 (2015) Nr. 1, S. 154 - 155
ISSN: 2213-6711Online Volltext: dx.doi.org/ (Open Access) -
Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myelomaIn: Leukemia Jg. 29 (2015) Nr. 8, S. 1721 - 1729
ISSN: 1476-5551; 0887-6924Online Volltext: dx.doi.org/ -
Recurrent CDKN1B (p27) mutations in hairy cell leukemiaIn: Blood Jg. 126 (2015) Nr. 8, S. 1005 - 1008
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Soluble HLA-E and HLA-E polymorphism predictors of early disease progression in CLLIn: Tissue Antigens Jg. 85 (2015) Nr. 5, S. 327 - 328
ISSN: 0001-2815; 1399-0039 -
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma : an interim analysis from the prospective GMMG-MM5 trialIn: Haematologica Jg. 100 (2015) Nr. 7, S. 964 - 969
ISSN: 0390-6078; 1592-8721Online Volltext: dx.doi.org/ (Open Access) -
Increases levels of soluble HLA-E are associated with advanced disease stage and early treatment requirement in chronic lymphoytic leukemiaIn: Tissue Antigens Jg. 84 (2014) Nr. 1, S. 139 - 139
ISSN: 0001-2815; 1399-0039 -
Multipotent hematopoietic progenitors divide asymmetrically to create progenitors of the lymphomyeloid and erythromyeloid lineagesIn: Stem Cell Reports Jg. 3 (2014) Nr. 6, S. 1058 - 1072
ISSN: 2213-6711Online Volltext: dx.doi.org/ (Open Access) -
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformationIn: American Journal of Hematology Jg. 89 (2014) Nr. 12, S. E239 - 43
ISSN: 0361-8609Online Volltext: dx.doi.org/ (Open Access) -
Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - a Randomized Controlled Trial Comparing Different Treatment Approaches Based on Interim PET Results (PETAL Trial)In: Blood Jg. 124 (2014) Nr. 21, S. 391
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Recurrent mutation of JAK3 in T-cell prolymphocytic leukemiaIn: Genes, Chromosomes and Cancer Jg. 53 (2014) Nr. 4, S. 309 - 316
ISSN: 1045-2257; 1098-2264Online Volltext: dx.doi.org/ -
Systematic mapping of drug sensitivity in hematological malignancies identifies vulnerability of chronic lymphocytic leukemia with mutant p53In: Cancer Research Jg. 74 (2014) Nr. 19 Suppl., S. 5557
ISSN: 0008-5472Online Volltext: dx.doi.org/ -
Bone turnover in multiple myeloma : Impact of bortezomib-based induction therapy, high-dose melphalan, and lenalidomide consolidation on osteoblast and osteoclast function within the GMMG-MM5 trialIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 38 - 38
ISSN: 0378-584X; 1423-0240 -
CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemiaIn: Blood Jg. 121 (2013) Nr. 20, S. 4126 - 4136
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
CLL associated immunodeficiencyIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 1 - 1
ISSN: 0378-584X; 1423-0240 -
Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1(+) effector memory phenotypeIn: Cancer Immunology, Immunotherapy Jg. 62 (2013) Nr. 11, S. 1697 - 1709
ISSN: 0340-7004; 1432-0851Online Volltext: dx.doi.org/ -
Gene expression profiling and its arrival in clinical routineIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 170 - 170
ISSN: 0378-584X; 1423-0240 -
Indolent T-cell lymphomas (T-LGL and others)In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 87 - 87
ISSN: 0378-584X; 1423-0240 -
Leukämien : Modellkrankheiten für die Entstehung und Behandlung von KrebsIn: Unikate: Berichte aus Forschung und Lehre (2013) Nr. 44: Medizin : 50 Jahre Universitätsklinikum Essen, S. 114 - 125
ISBN: 978-3-934359-44-4 ISSN: 0944-6060; 1869-3881Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Next generation transcriptome sequencing confirms the presence of somatic STAT3 mutations and identifies novel TNFAIP3 mutations in T Large Granular Lymphocytic Leukemia (T-LGL)In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 196
ISSN: 0378-584X; 1423-0240 -
Preclinical testing of a novel Axl-kinase inhibitor in Chronic Lymphocytic LeukemiaIn: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 172 - 172
ISSN: 0378-584X; 1423-0240 -
Prevalence and incidence of anemia in the German Heinz Nixdorf Recall StudyIn: Annals of Hematology Jg. 92 (2013) Nr. 6, S. 731 - 737
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ -
Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic LeukemiaIn: PLoS ONE Jg. 23 (2013) Nr. 8, S. e72107
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivoIn: Cancer Cell Jg. 23 (2013) Nr. 1, S. 77 - 92
ISSN: 1535-6108Online Volltext: dx.doi.org/ (Open Access) -
Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic LineagesIn: Cell Reports Jg. 3 (2013) Nr. 5, S. 1539 - 1552
ISSN: 2211-1247Online Volltext: dx.doi.org/ -
Abundance of a NOTCH1 mutated clone affects clinical outcome of patients with chronic lymphocytic leukemiaIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 97 - 97
ISSN: 0378-584X; 1423-0240 -
CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasmsIn: Leukemia Research Jg. 36 (2012) Nr. 9, S. 1204 - 1207
ISSN: 0145-2126; 1873-5835Online Volltext: dx.doi.org/ -
Cellular origin and pathophysiology of chronic lymphocytic leukemiaIn: Journal of Experimental Medicine Jg. 209 (2012) Nr. 12, S. 2183 - 2198
ISSN: 0022-1007; 1540-9538Online Volltext: dx.doi.org/ (Open Access) -
Combined SNP Microarray Based Genomic Mapping and Next Generation Transcriptome Sequencing Confirms the Presence of Somatic STAT3 Mutations and Identifies Novel Chromosomal Imbalances and Candidate Genes in T Large Granular Lymphocytic Leukemia (T-LGL)In: Blood Jg. 120 (2012) Nr. 21, S. 3512
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic LeukemiaIn: PLoS ONE Jg. 7 (2012) Nr. 12, S. e34347
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
Evaluation of free light-chain abnormalities as prognostic marker in Binet A stage chronic lymphocytic leukemiaIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 99 - 99
ISSN: 0378-584X; 1423-0240 -
Functional analyses of human hemtopoietic CD133(+)CD34(+) and CD133(LOW/-)CD34(+) cells challenge the existence of human common myeloid progenitor cellsIn: Experimental Hematology Jg. 40 (2012) Nr. 8, Suppl. 1, S. 124
ISSN: 0301-472X -
Lipid raft redistribution and morphological cell polarization are separable processes providing a basis for hematopoietic stem and progenitor cell migrationIn: The International Journal of Biochemistry & Cell Biology Jg. 44 (2012) Nr. 7, S. 1121 - 1132
ISSN: 1357-2725Online Volltext: dx.doi.org/ -
Molecular and morphological cell polarizationis required for human hematopoietic stem and progenitor cell migration and homingIn: Experimental Hematology Jg. 40 (2012) Nr. 8, Suppl. 1, S. S106 - S107
ISSN: 0301-472X -
Preclinical Testing of a Novel Axl-Kinase Inhibitor in Chronic Lymphocytic LeukemiaIn: Blood Jg. 120 (2012) Nr. 21,
ISSN: 0006-4971; 1528-0020 -
Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in GermanyIn: Annals of Hematology Jg. 91 (2012) Nr. 2, S. 243 - 248
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ -
Progranulin plasma concentration is a novel independent prognostic marker in chronic lymphocytic leukemiaIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 100
ISSN: 0378-584X; 1423-0240 -
Protein Kinase C-beta Dependent Activation of NF-kappa B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in VivoIn: Blood Jg. 120 (2012) Nr. 21, S. 314
ISSN: 0006-4971; 1528-0020 -
Serum immunoglobulin alterations in patients with chronic hepatitis CIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 142 - 143
ISSN: 0378-584X; 1423-0240 -
Toll-like receptor 9 agonists induce polarization and migration of chronic lymphocytic leukemia cellsIn: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 106
ISSN: 0378-584X; 1423-0240 -
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumabIn: Histochemistry and Cell Biology Jg. 137 (2012) Nr. 3, S. 391 - 401
ISSN: 0948-6143; 1432-119XOnline Volltext: dx.doi.org/ -
p53 protein expression in chronic lymphocytic leukemiaIn: Leukemia and Lymphoma Jg. 53 (2012) Nr. 7, S. 1282 - 1288
ISSN: 1042-8194; 1029-2403Online Volltext: dx.doi.org/ -
Association of soluble MICA levels to the MICA-129 polymorphism and treatment free survival in chronic lymphocytic leukaemia patientsIn: Tissue Antigens Jg. 77 (2011) Nr. 5, S. 393 - 393
ISSN: 0001-2815; 1399-0039; 2059-2310; 2059-2302 -
Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemiaIn: Blood Jg. 117 (2011) Nr. 24, S. 6450 - 6458
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft modelIn: European Journal of Haematology Jg. 87 (2011) Nr. 1, S. 10 - 19
ISSN: 1600-0609Online Volltext: dx.doi.org/ -
Monoclonal gammopathy of undetermined significance and solid tumor development in the Heinz Nixdorf Recall Study
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 243
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Novel human bone marrow stroma cell lines from a normal donor and leukemia and lymphoma patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 260
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Percentage of smudge cells on routine blood smears predict time to first treatment and overall survival in patients with Binet stage A chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 139
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Telomeres and prognosis in patients with chronic lymphocytic leukaemiaIn: International Journal of Hematology Jg. 93 (2011) Nr. 1, S. 74 - 82
ISSN: 1865-3774Online Volltext: dx.doi.org/ -
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemiaIn: Leukemia Jg. 25 (2011) Nr. 4, S. 638 - 647
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
705 Increased prevalence of monoclonal b lymphocytosis in patients with chronic Hepatitis CIn: Journal of Hepatology Jg. 52 (2010) Nr. Suppl. 1, S. S274
ISSN: 0168-8278; 1600-0641Online Volltext: dx.doi.org/ -
Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL)In: Journal of Clinical Oncology Jg. 28 (2010) Nr. Suppl. 15, S. 6520
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Dihydroartemisinin induces apoptosis by a bak-dependent intrinsic pathwayIn: Molecular Cancer Therapeutics Jg. 9 (2010) Nr. 9, S. 2497 - 2510
ISSN: 1538-8514; 1535-7163Online Volltext: dx.doi.org/ (Open Access) -
Gene dosage effects in chronic lymphocytic leukemiaIn: Cancer Genetics and Cytogenetics Jg. 203 (2010) Nr. 2, S. 149 - 160
ISSN: 1873-4456; 0165-4608Online Volltext: dx.doi.org/ -
Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia : Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II TrialIn: Clinical Lymphoma Myeloma & Leukemia Jg. 10 (2010) Nr. 3, S. E33 - E34
ISSN: 2152-2650; 2152-2669Online Volltext: dx.doi.org/ -
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemiaIn: Leukemia Research Jg. 34 (2010) Nr. 7, S. 892 - 898
ISSN: 1873-5835; 0145-2126Online Volltext: dx.doi.org/ -
Prevalence of monoclonal gammopathy of undetermindes significance in a densley populated, highly industrialized area in Germany
15th Congress of the European Hematology Association, Spain, Barcelona, June 10–13, 2010,In: Haematologica, the hematology journal: official organ of the European Hematology Association Jg. 95 (2010) Nr. Suppl. 2, S. 394, 0949
ISSN: 0390-6078; 1592-8721 -
Prognostic Significance of Molecular Remission in Follicular LymphomaIn: Journal of Clinical Oncology Jg. 28 (2010) Nr. 30, S. e613
ISSN: 1527-7755; 0732-183XOnline Volltext: dx.doi.org/ -
The impact of CD38 in the CLL NOD/SCID xenograft modelIn: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 200 - 201
ISSN: 0378-584X; 1423-0240 -
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemiaIn: Leukemia Jg. 24 (2010) Nr. 6, S. 1152 - 1159
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemiaIn: Leukemia and Lymphoma Jg. 50 (2009) Nr. 11, S. 1837 - 1842
ISSN: 1029-2403 -
Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemiaIn: European Journal of Haematology Jg. 83 (2009) Nr. 4, S. 320 - 327
ISSN: 1600-0609Online Volltext: dx.doi.org/ -
Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemiaIn: Leukemia Research Jg. 33 (2009) Nr. 6, S. 775 - 778
ISSN: 1873-5835Online Volltext: dx.doi.org/ -
FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemiaIn: European Journal of Haematology Jg. 83 (2009) Nr. 6, S. 541 - 549
ISSN: 1600-0609Online Volltext: dx.doi.org/ -
Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A–TCRAD juxtapositionIn: Cancer Genetics and Cytogenetics Jg. 192 (2009) Nr. 1, S. 44 - 47
ISSN: 1873-4456Online Volltext: dx.doi.org/ -
Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cellsIn: Leukemia Research Jg. 32 (2008) Nr. 10, S. 1565 - 1572
ISSN: 1873-5835Online Volltext: dx.doi.org/ -
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the diseaseIn: Cancer Research Jg. 67 (2007) Nr. 18, S. 8653 - 8661
ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemiaIn: Blood Jg. 109 (2007) Nr. 1, S. 290 - 297
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)In: Leukemia Jg. 21 (2007) Nr. 10, S. 2153 - 2163
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
Short telomeres and high telomerase activity in T-cell prolymphocytic leukemiaIn: Leukemia Jg. 21 (2007) Nr. 12, S. 2456 - 2462
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemiaIn: British journal of haematology Jg. 138 (2007) Nr. 2, S. 217 - 220
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survivalIn: Leukemia Jg. 20 (2006) Nr. 4, S. 724
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression statusIn: Leukemia Jg. 20 (2006) Nr. 10, S. 1774 - 1782
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemiaIn: Leukemia & Lymphoma Jg. 47 (2006) Nr. 6, S. 1053 - 1061
ISSN: 1029-2403Online Volltext: dx.doi.org/ -
The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemiaIn: Clinical cancer research Jg. 12 (2006) Nr. 19, S. 5686 - 5692
ISSN: 1557-3265Online Volltext: dx.doi.org/ -
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemiaIn: Leukemia Jg. 19 (2005) Nr. 5, S. 750 - 758
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaIn: Blood Jg. 105 (2005) Nr. 4, S. 1694 - 1698
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
B-cell chronic lymphocytic leukemia with aberrant CD8 expression : genetic and immunophenotypic analysis of prognostic factorsIn: Leukemia & Lymphoma Jg. 45 (2004) Nr. 8, S. 1677 - 1681
ISSN: 1029-2403Online Volltext: dx.doi.org/ -
Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantationIn: European journal of haematology Jg. 73 (2004) Nr. 1, S. 1 - 9
ISSN: 1600-0609Online Volltext: dx.doi.org/ -
Methylenetetrahydrofolate reductase (MTHFR) gene 677C>T and 1298A>C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemiaIn: Leukemia Jg. 18 (2004) Nr. 11, S. 1816 - 1823
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cellsIn: Blood Jg. 102 (2003) Nr. 6, S. 2146 - 2155
ISSN: 1528-0020; 0006-4971Online Volltext: dx.doi.org/ -
Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemiaIn: Blood Jg. 101 (2003) Nr. 7, S. 2748 - 2755
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Salvage chemotherapy according to the ASHAP protocol : a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomasIn: Annals of Hematology Jg. 82 (2003) Nr. 8, S. 481 - 486
ISSN: 1432-0584; 0939-5555; 0006-5242Online Volltext: dx.doi.org/ -
The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukaemiaIn: Leukemia & Lymphoma Jg. 44 (2003) Nr. 10, S. 1739 - 1743
ISSN: 1029-2403Online Volltext: dx.doi.org/ -
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemiaIn: Leukemia Jg. 17 (2003) Nr. 12, S. 2426 - 2434
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemiaIn: Leukemia Jg. 16 (2002) Nr. 1, S. 30 - 35
ISSN: 0887-6924; 1476-5551Online Volltext: dx.doi.org/ -
Differential expression of chemokine receptors in B cell malignanciesIn: Leukemia Jg. 15 (2001) Nr. 5, S. 752 - 756
ISSN: 1476-5551 -
Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrowIn: Growth Factors Jg. 19 (2001) Nr. 1, S. 1 - 17
ISSN: 1029-2292Online Volltext: dx.doi.org/ -
Biological effects of stroma-derived factor-1 alpha on normal and CML CD34+ haemopoietic cellsIn: Leukemia Jg. 14 (2000) Nr. 9, S. 1652 - 1660
ISSN: 1476-5551 -
Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytesIn: British journal of haematology Jg. 108 (2000) Nr. 3, S. 488 - 495
ISSN: 1365-2141Online Volltext: dx.doi.org/ -
Intercellular communication between bone marrow stromal cells and CD34+ haematopoietic progenitor cells is mediated by connexin 43-type gap junctionsIn: British journal of haematology Jg. 111 (2000) Nr. 2, S. 416 - 425
ISSN: 1365-2141; 0007-1048Online Volltext: dx.doi.org/ -
Prevalence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Light-Chain MGUS (LCMGUS) In a Metropolitan Area In GermanyIn: Blood: journal of the American Society of Hematology Jg. 116 (2010) Nr. 21, S. 4037
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Waldenström's Macroglobulinemia (MW) : Results of a Prospective, Randomized, Multicenter Phase 3 Study (the StiL NHL7-2008 MAINTAIN trial)
61st ASH Annual Meeting and Exposition, 07.-10.12.2019, Orlando, FL,In: Blood: journal of the American Society of Hematology Jg. 134 (2019) Nr. Supplement_1, S. 343
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma : The Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 448 - 448
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Four versus two years of Rituximab maintenance (R-maintenance) following Bendamustine plus Rituximab (B-R): initial results of a prospective, randomized multicenter phase 3 study in first-line follicular lymphoma (the StiL NHL7-2008 MAINTAIN study)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 251
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Gain of STAT3/5 locus is a recurrent cryptic aberration in T-cell prolymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 318
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
MP0250 Combined with Bortezomib and Dexamethasone in Multiple Myeloma Patients Previoulsy Exposed to Proteasome Inhibitors and Immunomodulatory Drugs
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 1980 - 1980
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Pomalidomide + Bortezomib + Low-Dose Dexamethasone Vs Bortezomib + Low-Dose Dexamethasone As Second-Line Treatment in Patients with Lenalidomide-Pretreated Multiple Myeloma : A Subgroup Analysis of the Phase 3 Optimismm Trial
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 3278 - 3278
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Pomalidomide, cyclophosphamide and dexamethasone in case of suboptimal response to pomalidomide and dexamethasone alone in relapsed and/or refractory multiple myeloma : Final results of the GMMG-PERSPECTIVE trial
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 133 - 134
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Preliminary data of the ongoing open-label, single-arm phase II study of MP0250 in combination with bortezomib plus dexamethasone in patients with relapsed refractory multiple myelomaIn: Haematologica Jg. 103 (2018) Nr. Suppl. 1,
ISSN: 1592-8721; 0390-6078 -
The DNA-methylation status of BCL11B in T-Cell-Large Granular Lymphocytic Leukemia - a diagnostic target
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 317
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Treatment Response and Long-Term Survival in Multiple Myeloma in the GMMG-HD4 Trial - Neither Profit All Molecular Entities Alike, Nor Are Remissions to Different Regimen Equal
60th ASH Annual Meeting; December 1-4, 2018; San Diego, USA,In: Blood Jg. 132 (2018) Nr. Supplement 1, S. 4485 - 4485
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
CDK9 Inhibition with LDC526 Is an Effective Treatment for T-Cell Prolymphocytic Leukemia (T-PLL) in VitroIn: Blood Jg. 130 (2017) Nr. Suppl. 1, S. 1262
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Epigenetic analyses of T-cell large granular lymphocytic leukemia identify differentially methylated enhancer regions leading to deregulation of gene interactionsIn: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 109 - 110
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Positron-emission tomography-guided therapy of aggressive non-Hodgkin lymphomas -final results of the PETAL trialIn: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 202 - 203
ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240Online Volltext: dx.doi.org/ -
Genomic profiling of T-cell Prolymphocytic Leukemia (T-PLL) identifies novel recurrent mutations in SAMHD1 and PTPRCIn: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Leipzig, 14.–18. Oktober 2016: Abstracts, S. 238 - 238
ISSN: 2296-5270Online Volltext: dx.doi.org/ -
Establishment of a real-time PCR assay to quantify the size of a NOTCH1 mutated subclone in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 60
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Expansion of a stimulatory natural killer receptor NKp80-expessing CD8+T-cell subset in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 191
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Preclinical testing of a novel CDK9 inhibitor in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 195 - 196
ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262Online Volltext: dx.doi.org/ -
Progranulin plasma levels predict time to first treatment and overall survival in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 196 - 196
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Role of the acid sphingomyelinase in hematogenous tumor metastasis in a mouse model
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Basel, 30.09.–04.10. 2011,In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 46
ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Association of HLA-G Haplotype Risk Model with Treatment Free Survival In Chronic Lymphocytic Leukemia PatientsIn: Blood Jg. 116 (2010) Nr. 21, S. 1002 - 1003
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Comparing the pharmacological effects of the novel Locked Nucleic Acid (LNA) modified antisense Bcl-2 inhibitor SPC2996 and G3139 (oblimersen) in preclinical models of chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 184
ISBN: 978-3-8055-9633-6 ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Expanded CD8(+) T-cells of murine and human B-CLL are driven into a senescent KLRG1(+) effector memory phenotypeIn: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 201
ISBN: 978-3-8055-9633-6 ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Expanded CLL CD8(+) T-Cells Are Driven Into a Senescent KLRG1(+) Effector Memory PhenotypeIn: Blood Jg. 116 (2010) Nr. 21, S. 403
ISSN: 0006-4971; 1528-0020 -
Heterogeneous Interactions of Leukemic and Control Bone Marrow Stroma Cells with an AML Cell Line and AML Leukemic BlastsIn: Blood Jg. 116 (2010) Nr. 21, S. 460
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
Heterogeneous interactions of leukemic and control bone marrow stroma cells with an AML cell line and AML leukemic blasts
Deutsche, Österreichische und Schweizerische Gesellschaften für Hämatologie und Onkologie Jahrestagung, Berlin, Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 235
ISBN: 978-3-8055-9633-6 ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
High soluble MICA levels are associated to MICA-129 val/val genotypes and poor treatment free survival in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 41 - 42
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Investigating the interaction of leukemic B and non-malignant T cells in a novel Rag2-/gamma c-/--xenograft model of human chronic lymphocytic leukemia (CLL)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 202
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costsIn: Onkologie Jg. 33 (2010) Nr. 12, S. 658 - 664
ISSN: 1423-0232; 0030-2414; 0369-7606Online Volltext: dx.doi.org/ -
Polyclonal B-Cell activation and Expansion of Monoclonal B Cells in the Peripheral Blood of Patients with Chronic Hepatitis CIn: Hepatology Jg. 52 (2010) Nr. Suppl. 1, S. 740A
ISSN: 0270-9139; 1527-3350Online Volltext: dx.doi.org/ -
Prevalence of B cell lymphoproliferative disorders in patients with chronic hepatitis C (CHC)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010, pp 109–206,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 157
ISBN: 978-3-8055-9633-6 ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Role of the antigenic stimulation in the pathogenesis of chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 39
ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/ -
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 42
ISBN: 978-3-8055-9633-6 ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Large Granular Lymphocyte LeukemiaIn: Chronic Lymphocytic Leukemia / Hallek, Michael; Eichhorst, Barbara; Catovsky, Daniel (Hrsg.) 2019, S. 167 - 179
ISBN: 978-3-030-11391-9; 978-3-030-11392-6Online Volltext: dx.doi.org/